Mind Medicine (MindMed) Inc. (MNMD)
NASDAQ: MNMD · IEX Real-Time Price · USD
7.93
-0.30 (-3.65%)
At close: Jul 19, 2024, 4:00 PM
8.05
+0.12 (1.51%)
Pre-market: Jul 22, 2024, 7:11 AM EDT
Mind Medicine (MindMed) Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for MNMD stock have an average target of 25.86, with a low estimate of 20 and a high estimate of 36. The average target predicts an increase of 226.10% from the current stock price of 7.93.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jun 5, 2024.
Analyst Ratings
The average analyst rating for MNMD stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 3 | 3 | 3 |
| Buy | 3 | 3 | 3 | 5 | 5 | 5 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 6 | 6 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jun 21, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $22 | Buy | Reiterates | $22 | +177.43% | Jun 5, 2024 |
| Baird | Baird | Buy Initiates $27 | Buy | Initiates | $27 | +240.48% | May 28, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $35 | Strong Buy | Reiterates | $35 | +341.36% | May 24, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $29 → $20 | Buy | Reiterates | $29 → $20 | +152.21% | May 13, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.96
from -2.44
EPS Next Year
-1.54
from -1.96
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | n/a | 420.9M | 996.4M |
| Avg | n/a | n/a | n/a | 104.8M | 326.5M |
| Low | n/a | n/a | n/a | n/a | 60.3M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | 851.0% |
| Avg | - | - | - | - | 211.6% |
| Low | - | - | - | - | -42.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.74 | -1.43 | -1.14 | 1.51 | 5.32 |
| Avg | -1.96 | -1.54 | -1.62 | -0.99 | 0.61 |
| Low | -2.16 | -1.78 | -2.08 | -2.52 | -1.74 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.